Article Text

other Versions

PDF
20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits
  1. Seema R Lalani (seemal{at}bcm.tmc.edu)
  1. Baylor College of Medicine, United States
    1. Joseph V Thakuria (joseph.thakuria{at}gmail.com)
    1. Children’s Hospital Boston, United States
      1. Gerald F Cox (gerald.cox{at}genzyme.com)
      1. Children’s Hospital Boston, United States
        1. Xueqing Wang (xueqingw{at}bcm.tmc.edu)
        1. Baylor College of Medicine, United States
          1. Weimin Bi (wbi{at}bcm.tmc.edu)
          1. Baylor College of Medicine, United States
            1. Molly S Bray (mbray{at}bcm.tmc.edu)
            1. Baylor College of Medicine, United States
              1. Chad Shaw (cashaw{at}bcm.tmc.edu)
              1. Baylor College of Medicine, United States
                1. Sau W Cheung (scheung{at}bcm.tmc.edu)
                1. Baylor College of Medicine, United States
                  1. A Craig Chinault (chinault{at}bcm.tmc.edu)
                  1. Baylor College of Medicine, United States
                    1. Barbara A Boggs (bboggs{at}bcm.tmc.edu)
                    1. Baylor College of Medicine, United States
                      1. Zhishuo Ou (zhishuoo{at}bcm.tmc.edu)
                      1. Baylor College of Medicine, United States
                        1. Ellen K Brundage (ellenb{at}bcm.tmc.edu)
                        1. Baylor College of Medicine, United States
                          1. James R Lupski (jlupski{at}bcm.tmc.edu)
                          1. Baylor College of Medicine, Texas Children's Hospital, United States
                            1. Jennifer Gentile (jennifer.gentile{at}childrens.harvard.edu)
                            1. Children’s Hospital Boston, United States
                              1. Susan Waisbren (susan.waisbren{at}childrens.harvard.edu)
                              1. Children’s Hospital Boston, United States
                                1. Amber Pursley (pursley{at}bcm.tmc.edu)
                                1. Baylor College of Medicine, United States
                                  1. Lijiang Ma (lijiang.ma{at}mdanderson.org)
                                  1. Institute of Biosciences and Technology, Texas A&M System Health Science Center, United States
                                    1. Mehrdad Khajavi (mkhajavi{at}bcm.tmc.edu)
                                    1. Baylor College of Medicine, United States
                                      1. Gladys Zapata (gzapata{at}bcm.tmc.edu)
                                      1. Baylor College of Medicine, United States
                                        1. Richard Friedman (richardf{at}bcm.edu)
                                        1. Baylor College of Medicine, United States
                                          1. Jeffrey J Kim (jjkim{at}texaschildrenshospital.org)
                                          1. Baylor College of Medicine, Texas Children's Hospital, United States
                                            1. J A Towbin (jtowbin{at}bcm.tmc.edu)
                                            1. Baylor College of Medicine, Texas Children's Hospital, United States
                                              1. Pawel Stankiewicz (pawels{at}bcm.tmc.edu)
                                              1. Baylor College of Medicine, United States
                                                1. Susanne Schnittger (susanne.schnittger{at}mll-online.com)
                                                1. MLL Munich Leukemia Laboratory, Germany
                                                  1. Ingo Hansmann (ingo.hansmann{at}medizin.uni-halle.de)
                                                  1. Institut für Humangenetik und Medizinische Biologie, Halle/Saale, Germany
                                                    1. Tomohiko Ai (tomohika{at}bcm.tmc.edu)
                                                    1. Baylor College of Medicine, United States
                                                      1. Subeena Sood (sood{at}bcm.tmc.edu)
                                                      1. Baylor College of Medicine, United States
                                                        1. Xander H Wehrens (wehrens{at}bcm.tmc.edu)
                                                        1. Baylor College of Medicine, United States
                                                          1. James F Martin (jmartin{at}ibt.tamhsc.edu)
                                                          1. Institute of Biosciences and Technology, Texas A&M System Health Science Center, United States
                                                            1. John W Belmont (jbelmont{at}bcm.tmc.edu)
                                                            1. Baylor College of Medicine, United States
                                                              1. Lorraine Potocki (lpotocki{at}bcm.tmc.edu)
                                                              1. Baylor College of Medicine, United States

                                                                Abstract

                                                                Background: Wolff-Parkinson-White syndrome (WPW) is a bypass reentrant tachycardia that results from an abnormal connection between the atria and ventricles. Mutations in PRKAG2 have been described in patients with familial WPW syndrome and hypertrophic cardiomyopathy. Based on the role of bone morphogenetic protein (BMP) signaling in the development of annulus fibrosus in mice, it has been proposed that BMP signaling through the type 1a receptor and other downstream components may play a role in preexcitation.

                                                                Methods and Results: Using the array comparative genomic hybridization (CGH), we identified five individuals with non-recurrent deletions of 20p12.3. Four of these individuals had WPW syndrome with variable dysmorphisms and neurocognitive delay. With the exception of one maternally inherited deletion, all occurred de novo, and the smallest of these, harbored a single gene, BMP2. In two individuals with additional features of Alagille syndrome, deletion of both JAG1 and BMP2 were identified. Deletion of this region has not been described as a copy-number variant in the Database of Genomic Variants and has not been identified in 13,321 individuals from other cohort examined by array CGH in our laboratory.

                                                                Conclusions: Our findings demonstrate a novel genomic disorder characterized by deletion of BMP2 with variable cognitive deficits and dysmorphic features and show that individuals bearing microdeletions in 20p12.3 often present with WPW syndrome.

                                                                Statistics from Altmetric.com

                                                                • web only appendices 46/3/168

                                                                  • web only statement

                                                                    Seema R Lalani and Joseph V Thakuria are the co-first authors of this paper.

                                                                    Request permissions

                                                                    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.